Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Mar 6 executedMar 10, 2026 disclosed
ACAD · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
ACADIA PHARMACEUTICALS INC — Stock Option (Right to Buy)
Ticker
ACAD
Shares
97.9K
Price per share
$0
Execution date (reported)
Mar 6, 2026
Owned after transaction
97.9K shares
Days from execution to publication
4
What this establishes
Garner Thomas filed this Form 4 reporting a grant or award of ACAD on Mar 6, 2026. It became public on Mar 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP, Chief Commercial Officer
Garner Thomascik:0001996325
Issuer
ACADIA PHARMACEUTICALS INCcik:0001070494
Revision history · 0
No field has changed since this record was first ingested.
